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ABSTRACT
TNFa-DEPENDENT AND TNFa-ENDEPENDENT ACTIVATION QF 
MACROPHAGE EFFECTOR FUNCTION 
by
Annette R. Clemons-Miller
Tumor necrosis factor a (TNFa) is a pleiotropic cytokine that is predominantly produced 
by activated macrophages. The effects ofTNFa are as diverse as the cells with which it 
interacts, e.g., stimulating fibroblast growth, exerting cytotoxic/cytostatic activity against 
various human and murine cell lines, promoting inflammation through upregulation of 
endothelial adhesion molecules and IL-8 production. Yet TNFa is best known, and in fact 
was originally described, for its role in the bacterial-induced hemorrhagic necrosis of 
tumors and exacerbation of septic shock in which aberrant TNFa production leads to 
vascular collapse, cachexia, multiple organ failure, and ultimately death in as many as 
100,000 people each year in the United States alone.
LPS, a component of the outer cell wall of gram-negative bacteria, is the principal inducer 
of macrophage TNFa production. TNFa production can be enhanced by IFNy which also 
induces upregulation ofTNFa receptors allowing for the establishment of a TNFa 
autocrine loop. It has been hypothesized that autocrine TNFa stimulation plays a critical 
role in the induction of macrophage effector function, e.g., nitric oxide production. This 
dissertation represents efforts to evaluate the respective roles of the TNFa receptors in the 
induction of macrophage effector function, in addition to examining the mechanism by 
which autocrine TNFa exerts its effects on macrophages.
Exploiting the species specificity of the murine TNFa receptor type 2 (TNF-R2), splenic 
macrophages were stimulated with human TNFa (which binds to TNF-Rl but not TNF- 
R2), in the presence of IFNy. Human TNFa was effective in the induction of nitric oxide 
production, albeit at concentrations 12.5-fold greater than those required by murine TNFa 
to achieve the same result. Addition of anti-TNF-Rl completely inhibited the murine 
TNFa mediated induction of macrophage effector function. However, treatment with 
anti-TNF-R2 resulted in partial inhibition of macrophage activation. Taken together this 
data suggests that the primary TNFa mediated signals involved in macrophage activation 
are transduced through TNF-Rl, although TNF-R2 appears to contribute to the intensity 
of the macrophage response.
To evaluate the role of autocrine TNFa signaling in the induction of macrophage effector 
function, immortalized macrophages from normal C57B1/6J mice (B6/J2) and C57B1/6J 
mice containing gene targeted disruptions of the TNF-Rl and TNF-R2 genes (TRN) were
111
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stimulated under CD 14-dependent and CD 14-independent conditions. Although the 
B6/J2 and TRN clones mounted similar NO responses to LPS in the presence of serum, 
the TRN macrophages generated a weak nitric oxide response as compared to B6/J2 when 
stimulated with LPS under serum-free conditions. The involvement ofTNFa autocrine 
stimulation in the CD 14-independent activation was corroborated by the ability of soluble 
TNF-Rl to inhibit the response of B6/J2 macrophages to LPS in serum-free medium.
CD 14-independent LPS stimulation of TRN and B6/J2 resulted in equivalent levels of EL- 
IP, TNFa, and iNOS gene expression, as determined by RT-PCR, and in release of 
equivalent amounts of biologically active TNFa. However, western blot analysis revealed 
that iNOS protein production by TRN was as much as 50% less than that produced by 
B6/J2. These results indicate that autocrine TNFa stimulation contributes to the signaling 
pathways initiated by ligation of CD 14-independent LPS receptors and may be involved in 
iNOS post-transcriptional regulation.
IV
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CHAPTER 1 
INTRODUCTION
Macrophage Origin and Functions 
Macrophages are derived from myelocytic precursors in the bone marrows that 
initially differentiate into circulating monocytes that eventually migrate into the 
extravascular tissues and terminally differentiate into mature macrophages \  Monocyte 
migration into the tissues appears to be a random event with macrophages found 
throughout the body including the liver (Kupffer cells), lung (alveolar macrophages), 
connective tissue (histiocytes), spleen, bone (osteoclasts), central nervous system 
(microglia), skin (Langerhans’ cells), peritoneal and pleural cavities \  Interestingly, 
macrophages appear to be a product of their environment, that is to say that the 
functional, morphological, and phenotypic heterogeneity of a certain macrophage 
population reflects the local conditions to which they are subjected during their 
maturation
Macrophages were first characterized by Elie Metchnikoff in the late 1800s as 
mediators of harmonization The basic tenet of his theory still holds true in that many of 
the roles of macrophages revolve around maintaining “harmony” within the immune 
system. These roles can be divided into five generic functional activities encompassing 
both innate and acquired immunity: phagocytosis, effector function, inflammatory 
function, anti-inflammatory function, and accessory function * (Figure 1).
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
Co-stimulatmy PHAGOCYTOSIS
Membrane Ligands A  Nitric Oxide
(c.g, CD80) I Production
Antigen ^ — ACCESSORY FUNCTION ^  E FFE C T O R  FU NCTION — ►- Oxidative Burst
Co-stimulatoty Metalloproteinasc
cytokines   Secretion
(e.g, IL-l) ANTI-INFLAMM ATORY INFLAMMATORY
FUNCTION FUNCTION
Chemokines IL-l Arachfdonic
TGF-p
IL-« Acid
TNFa Metabolites
Figure 1. The Many Functions of Macrophages.
One o f the major effector functions displayed by macrophages is the production of 
reactive nitrogen intermediates. The generation of reactive nitrogen intermediates, 
specifically production of nitric oxide, involves the induction o f a calcium-independent 
macrophage isoform of nitric oxide synthase, inducible nitric oxide synthase (iNOS) 
iNOS is a NADPH-dependent, cytosolic enyzme that catalyzes the oxidation of the 
terminal guanido-nitrogen of L-arginine resulting in the formation of stoichiometric 
amounts of L-citrulline and nitric oxide (NO) Stimulation o f macrophages with either
LPS or TNFa in the presence of IFNy results in the tightly regulated transcription of 
iNOS synthesis Transcription of iNOS is controlled through binding of specific DNA 
binding proteins to two regions (region I and H) in the promoter/enhancer elements of the 
iNOS gene. Region I and II have been shown to be necessary for the LPS-activated 
expression iNOS, whereas region H alone was found to mediate IFNy regulation and 
acted primarily as an enhancer of iNOS induction “ . Both regions were found to contain
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3binding sites for numerous DNA binding proteins. Specifically, consensus binding 
sequences for NF-IL6, NF-kB, and TNF-REs were found within region I, while IFN- 
responsive elements (e.g., IRF-1) were concentrated in region II
Once induced, iNOS is capable of producing locally high levels of NO, far greater 
than those produced by other nitric oxide synthase isoforms, making it a major effector 
molecule in the defense against certain tumor cells, parasitic fungi, protozoa, helminths, 
and mycobacteria However, the toxic levels of NO are not only effective against 
microbicidal invâders but are also capable of damaging normal host tissues, potentially 
contributing to autoimmune tissue destruction NO appears to exert its effects through 
DNA damage or the inactivation of cellular metabolic pathways. Specifically, NO can 
react with the iron-sulfur-containing enyzmes, such as aconitase and complexes I and H of 
the mitochondrial electron transport chain, resulting in the formation of nitrosyl iron 
complexes, rendering the enzyme inactive Thus, the production of NO by activated 
macrophages is a major effector molecule employed in the nonspecific aspect of the 
immune response.
The inflammatory and anti-inflammatory functions of macrophages primarily 
involve the production of specific immunomodulatory cytokines. The major inflammatory 
cytokines produced by macrophages include TNFa, IL-l, and IL-6 These three 
cytokines constitute the basis of the proinflammatory cascade in which EL-1 and TNFa can 
not only enhance the production of themselves and each other, but both can also enhance 
the production of IL-6 The effects of EL-1 are seemingly limitless: it is chemotactic, 
pyrogenic, induces the expression of selectins and intercellular adhesion molecules
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4(ICAMs) on vascular endothelium, induces the production o f collagenase, 
metalloproteinases, and PGEj, and stimulates bone and cartilage resorption TNFa, 
which will be discussed in detail later, is as intimately involved in the inflammatory 
response as IL-l, oflien with their effects overlapping each other The anti­
inflammatory aspect of macrophage function involves another set of immunomodulatory 
cytokines, which include TGF-P, IL-10, and the IL-l receptor antagonist (IL-lRa).
TGF-P can exert both stimulatory and inhibitory effects. The stimulatory effects 
include the enhancement of matrix protein synthesis by fibroblasts, osteoblasts, and 
endothelial cells, induction of osteoblast proliferation, fibroblast chemotaxis, and the 
production of collagenase, all of which play a role in fibrosis and the promotion of wound 
healing \  TGF-P has also been shown to inhibit not only all known IL-2 effects \  but it 
also inhibits the actions o f several other cytokines including the activation of macrophages 
by IFNy IL-IO, which is produced not only by macrophages but also by mast cells,
T cells, B cells, and kératinocytes is an immunosuppressive agent that inhibits 
proinflammatory cytokine production (e.g., IL-l, TNFa, IL-6) reduces macrophage 
expression of class IIM HC molecules and reduces nitric oxide production The IL- 
IRa, which can be induced by either IL-l or TNFa, appears to function primarily as a 
feedback inhibitor in the production of IL-l and TNFa
Thus far, the macrophage functions discussed revolve around the macrophage’s 
role in nonspecific (innate) immunity. However, accessory function, the fifth and final 
macrophage function to be discussed, describes the macrophage’s role in acquired 
immunity.
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As accessory cells, macrophages perform not only their classical function of 
antigen presentation but also assist in T cell activation through contact-dependent and 
contact-independent mechanisms. The contact-independent mechanisms involve the 
production o f costimulatory cytokines such as IL-l, TNFa, and IL-6 The contact- 
dependent mechanism, as the name implies, involves surface to surface interaction 
between the T cell and macrophage. To enable this conjugation the macrophage expresses 
ligands (e.g., CD80, CD86) and receptors (e.g., CD40, LFA-1) that are specific for 
receptors (e.g., CD28, CD 152) and ligands (e.g., CD 154,1-CAM) on the T cell (Figure 
2).
T C ell
CD154
lCDl52Wi;CD40L)
Macrophage/Monocyte 
Figure 2. Cartoon Depiction of T Cell/Macrophage Contact Dependent Interactions.
Recent studies have suggested that the contact-dependent signaling between T 
cells and macrophages is a reciprocal event— that is, not only does the macrophage 
provide cognate co-stimulation for the T cell, but it is also the recipient of cognate co­
stimulation fi'om the T cell. The contact-dependent, reciprocal activation of macrophages 
by T cells was best illustrated by studies in which either paraformaldehyde-fixed or
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purified membrane preparations from activated T cells were capable o f inducing 
macrophages/monocytes to produce either NO or IL-l and TNFa The T cells used 
in the studies above were activated to induce the expression of CD 154 (CD40L) prior to 
addition to the macrophage cultures. CD 154, a transiently expressed protein that is 
maximally expressed following 5-10 hrs of activation binds to CD40 which is
functionally expressed on B cells, vascular endothelial cells, epidermal dendritic cells, 
fibroblasts, and monocytes/macrophages The involvement of CD40:CD154 
interactions in humoral immune responses (e.g., B cell activation and differentiation, 
immunoglobulin class switching) has been well established While the involvement of 
CD40;CD154 in cell-mediated inflammatory responses such as multiple sclerosis and 
experimental allergic encephalitis has only recently begun to be investigated, the possibility 
o f CD40:CD154 induced TNFa participating in the autocrine activation of 
macrophages/monocytes has yet to be addressed
TNFa: The Molecule 
TNFa was originally described by its ability to cause hemorrhagic necrosis and was 
found to be identical to the mononuclear cell-derived factor “cachectin”, which had been 
shown to mediate shock in gram-negative sepsis. In addition to septic shock, aberrant 
TNFa production has been shown to be involved in the exacerbation o f cerebral malaria, 
bacterial meningitis, graft-versus-host disease, and a number of autoimmune diseases 
Under “normal” circumstances, TNFa plays an important role as an immunostimulator and 
mediator o f host resistence to many infectious agents
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TNFa is produced predominantly by activated macrophages but can also be 
produced by a number of other cell types including endothelial cells, smooth muscle cells, 
astrocytes, CD4-I- and CD8+ T cells, kératinocytes, mast cells, and dendritic cells 
The effects ofTNFa are as diverse as the cells with which it interacts— e.g. stimulating 
fibroblast growth by enhancing the expression of c-myc and c-fos exerting 
cytotoxic/cytostatic activity against various human and murine cell lines and promoting 
inflammation by inducing endothelial cells to secrete IL-8 and to express adhesion 
molecules such as ELAM-1 and ICAM-1 To date no specific TNFa induced biologic 
activity has been defined that is common to all TNFa-responsive cells
TNFa, the patriarchal member of the TNFa superfamily can interact with its
target cells either as a transmembrane or soluble protein TNFa, along with other 
members o f the TNFa superfamily, is synthesized as a type II transmembrane protein 
characterized by the extracellular C-terminus The secreted form is generated by 
proteolytic cleavage of the 26 kDa membrane bound protein by the 85 kDa TNFa 
converting enzyme (TACE) The cleavage event results in the release of a 17 kDa 
monomer that normally circulates as a noncovalently bound homotrimer
The three-dimensional shape of the TNFa homotrimer has been described as a 
triangular cone. Each of the three subunits has a typical jelly roll-P structure characterized 
by the two P-pleated sheets and five anti-parallel P-strands While the outside P-sheet is 
rich in hydrophilic residues, the inner sheet is hydrophobic and contains the C-terminal 
segment located close to the central axis of the trimer Mutational analyses have
mapped the active region of the TNFa molecule to the lower half of the triangular pyramid
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8in the groove created between each of the subunits which corresponds to the receptor 
binding domain
TNFa: The Receptors 
Two receptors have been characterized that show high binding affinity for TNFa, 
TNFa-receptor type 1 (TNF-Rl) and TNFa-receptor type 2 (TNF-R2), which bind TNFa 
with Kj values of 0.5 nM and 0.1 nM, respectively TNF-Rl and TNF-R2 belong to a 
family of receptors referred to as the TNFa receptor superfamily which consists not only 
of the TNFa receptors but also LT-P receptor. Fas (CD95/Apol), CD40, CD30, CD27, 
p75 NGF receptor, OX-40, 4-lBB, mediator of herpes simplex virus entry, and death 
domain-containing receptor 3 (DR3) This superfamily is characterized by an 
extracellular domain that can be divided into four roughly repeating cysteine-rich domains 
which share significant intersubunit sequence homology Noting the trimeric
structure of the members of the TNFa superfamily, it has been suggested that the 
receptors in the TNFa receptor superfamily undergo receptor clustering during signal 
transduction (Figure 3).
Homology between the two TNFa receptors, 20% amino acid sequence identity 
within the extracellular domain and 5% within the cytoplasmic domain is not any 
greater than between other members of this family ■**. The lack of homology within the 
intracellular domains of TNF-Rl and TNF-R2 suggests that each receptor uses a different 
signaling pathway Stimulation through TNF-Rl has been linked to the activation of
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Figure 3. Model for TNFa Binding to TNFa Receptors.
NF-kB, accumulation of mRNA for c-fos and IL-6, surface expression of IL-2R and HLA 
Class I and Class H, inhibition of cell growth, and cytotoxicity In contrast, TNF-R2 has
been shown to be involved in the TNFa-dependent proliferative responses of peripheral 
blood lymphocytes and thymocytes, induction of GM-CSF secretion, inhibition o f early 
hematopoiesis, and the upregulation of costimulatory molecules
The cloning o f the two murine TNFa receptors demonstrated that although TNF- 
R l had a similar affinity for both recombinant mTNFa and hTNFa, TNF-R2 showed 
affinity for only mTNFa, thus defining TNF-R2 as a species-specific receptor (Figure 4). 
The ability o f hTNFa to bind to TNF-Rl but not to TNF-R2 provides a model allowing 
separation o f TNF-Rl mediated effects from TNF-R2 effects Using this model, 
TNF-Rl was found to mediate most of the biological effects ofTN Fa including initiation
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Human TNFa Murine TNFa
Murine TNF-Rl Murine TNF-R2
Figure 4. Species Specificity o f the Murine TNF-Receptor 2.
of cellular cytotoxicity and apoptosis enhancement of oxidative burst as
well as mediation o f systemic shock during sepsis
Like many other cytokine receptors, TNF-Rl and TNF-R2 do not contain tyrosine 
kinase domains within their intracellular domains thus the mechanism(s) by which the 
two receptors initiate their respective signal cascades has remained cryptic. The lack of 
intrinsic tyrosine kinase activity generally suggests that ligand-receptor interactions result 
in receptor clustering leading to association of active signaling molecules with the receptor 
Through the implementation of the yeast-two hybrid screening method several such 
TNF receptor-associated molecules have been identified and are depicted in Figure 5. Of 
the TNF receptor associated molecules that have been studied, most appear to be involved 
in the activation of NF-kB and/or the induction of apoptosis
TNFa Autocrine Loop 
The production ofTNFa by macrophages and their concomitant expression of 
TNFa receptors implies that TNFa autocrine stimulation could play a critical role in the
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
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TNF-R1
TNF-R2
Figure 5. Cartoon of the Identified TNF-Receptor Associated Signaling Molecules.
induction of macrophage effector function, such as nitric oxide production This role 
has been supported by studies in which anti-TNFcc neutralizing antibodies inhibited the 
ability of LPS and IFNy to induce macrophage effector functions as well as the 
observation that recombinant TNFa, in the presence of XFNy was sufficient for the 
induction of macrophage effector function Noting the critical role that autocrine TNFa 
plays in the LPS-mediated induction of macrophage effector function, it is conceivable 
that TNFa activates the signaling pathway(s) that are crucial for the synergistic response 
to LPS and IFNy.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
12
This dissertation was designed not only to evaluate the respective roles o f the two 
TNFa receptors in the induction of macrophage effector function, but also to examine the 
mechanism by which TNFa exerts its effects on macrophages. Specifically, the question 
of the involvement of a TNFa autocrine loop in the induction of macrophage activation 
has been addressed utilizing macrophage lines with targeted disruptions of the TNFa 
receptors.
Gaining an understanding of the means by which TNFa activates macrophage 
effector function, and through which TNFa receptor those effects are mediated will allow 
for potential targets for intervention and regulation of aberrant TNFa production.
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CHAPTER 2 
MATERIALS AND METHODS
Reagents
Recombinant murine TNFa, human TNFa, and murine GM-CSF were obtained 
from Genzyme Corp. (Cambridge, MA). The specific activity reported by Genzyme was 
6.67 X 10  ^U/ng for murine TNFa, 5.56 x 10  ^U/ng for human TNFa, and 7.8 x 10"* U/ng 
for the GM-CSF. Recombinant murine IFNy was acquired from Amgen Biologicals 
(Thousand Oaks, CA) and R&D Systems (Minneapolis, MN). Recombinant soluble 
murine TNFa-receptor type I was obtained from R&D Systems (Minneapolis, MN). 
Bacterial lipopolysaccharide (LPS; from Escherichia coli 0 1 1;B4-W) and gentamicin 
were obtained from Sigma Chemical Co. (St. Louis, MO). Fetal bovine serum (FBS; 
prescreened for endotoxin levels of < 0.05 ng/ml) was purchased from HyClone 
Laboratories, Inc. (Logan, UT) and Atlanta Biologicals (Norcross, GA).
Endotoxin Screening 
All tissue culture reagents used were either certified as containing no, or low, 
endotoxin when purchased, or were assayed for endotoxin concentration by chromogenic 
limulus assay (Sigma). Stock solutions containing >1 ng/ml (10 EU/ml) were considered 
unsuitable for use. Stock solutions were diluted in assays such that endotoxin levels did 
not exceed 1 pg/ml.
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Media
Complete culture media for macrophage activation (R5 + 2-ME) contained RPMI 
1640 with L-glutamine (HyClone Laboratories), supplemented with 5% heat-inactivated 
FBS (HI-FBS), 10 mMHEPES (A''-2-hydroxyethylpiperazine-A'-2-ethanesulfom'c acid; 
Sigma Chemical Co.), and 50 pM 2-mercaptoethanol (Sigma Chemical Co.). The culture 
medium for generation of macrophages from murine spleen cells (R5) was the same as the 
macrophage activation media described above except 2 -mercaptoethanol was not 
included. Serum-free media was obtained from Gibco-BRL (Grand Island, NY).
Antibodies
Purified polyclonal antisera to murine TNF-Rl and TNF-R2 were generously 
provided by Genentech, Inc. (San Francisco, CA). Phycoerythrin-labeled monoclonal rat 
anti-mouse TNF-Rl and TNF-R2 were obtained from Caltag Laboratories (Burlingame, 
CA). Fluorescein conjugated NeutraLite avidin was obtained from Molecular Probes 
(Eugene, OR).
The following monoclonal antibodies (mAbs) were collected from culture 
supernatants from the appropriate hybridomas: rat anti-mouse Mac-1 anti I-A’’*'* (28-16- 
8 S) rat anti-mouse CD4 (GK-1.5) **, rat anti-mouse CDS (53-6.72) rat anti-mouse 
ThB (49h4) and the rat anti-mouse macrophage (F4/80) (American Type Culture 
Collection, Rockville, MD). The anti-MAC-1 was purified over a protein G-sepharose 4B 
afSnity column (Pharmacia LKB Biotech, Inc., Piscataway, NJ) followed by dialysis and 
sterile filtration prior to use.
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Animals
Inbred female C57BL/6J mice were obtained from Jackson Laboratories (Bar 
Harbor, ME), while breeding pairs of the TNF-R1/TNF-R2 homozygous double knockout 
mice were provided by Genentech, Inc. (San Francisco, CA). Only mice between the ages 
of 6  and 14 weeks were used for experimentation.
Cell Lines
The macrophage line RAW 264.7 and L929 fibroblasts were obtained from 
American Tissue Type Culture Collection (Rockville, MD). ijfCRE/J2 was generously 
donated by Dr. George Cox (NHL Bethesda, MD).
Macrophage Cultures
Splenic macrophages were generated as previously described in detail Briefly, 
spleen cells resuspended to 4-4.5 x lOVml in R5 were added to a 96-well microtiter 
culture plate in 0.2 ml aliquots. Following a culture period of 5 days, nonadherent cells 
were removed by washing with Dulbecco’s phosphate-buffered saline (DPBS) 
supplemented with 2 % HI-FBS. Peritoneal cells were obtained following peritoneal 
lavage of the mice with a 4:1 PBS/Citrate (3.4%) buffer. The peritoneal cells were then 
resuspended to I x lOVml in R5, added to a microtiter plate in 0 .2  ml aliquots, and 
allowed to adhere overnight. RAW 264.7 maintained in R5 were harvested and 
resuspended to 1 x lOVml and added to a microtiter plate in 0.2 ml aliquots.
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and allowed to adhere overnight. The virally transformed macrophage lines and/or clones 
were maintained in R5.
Generation of TNFR-l/TNFR-2 -/- Macrophage Line 
J2-immortalized macrophage lines were generated from both C57B1/6J (B6/J2) and 
TNFR-l/TNFR-2 -/- (TRN) mice as previously described Briefly, density gradient 
purified bone marrow (Lympholyte-M, Atlanta Biologicals) from both hind limbs was 
resuspended in 5 ml i|;CRE/J2 supernatant supplemented with 5% HlFBS, which had been 
filtered through a 0.45 pm filter, and placed into a Nunc™ T-25 vented cap flask (Fisher 
Scientific). Polybrene (Sigma Chemical Co.) and murine GM-CSF were added to the 
culture at final concentrations of 5 pg/ml and 10 ng/ml, respectively. Following an 
overnight incubation, the media was removed and replaced with fresh R5 supplemented 
with an additional 5% HIFBS and 10 ng/ml GM-CSF. After 7 days o f culture the 
supernatant was discarded and the cells were rinsed gently with R5 and placed back in 
culture in R5 with GM-CSF. Macrophage clones were then obtained by limiting dilution. 
Once well established, the clones were maintained in R5 without GM-CSF. The resulting 
cells were then assayed for macrophage distinctive surface phenotype (MAC-H-, F4/80+-) 
and for macrophage function.
TNFa Assav
Bioactivity o f TNFa in the culture supernatants was determined by the L929 
bioassay as previously described L929 fibroblasts treated with 4 pg/ml actinomycin D
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were plated at 5 x 10^  cells/well with or without culture supernatants and incubated at 
37°C overnight. The supernatant was then removed and replaced with lOOpl 0.2% crystal 
violet. After 5 min, the plate was rinsed with tap water 6-7 times and blotted dry. To 
each of the wells, lOOpI 1% SDS (Fisher Scientific) was then added. The plate was 
shaken and the ODjjg read using an automated plate reader. TNFa concentration was 
calculated from a standard curve.
Nitrite Assav
Production of nitrite was detected by a microplate colorimetric assay as described 
previously Briefly, 100 pi macrophage culture supernatant was combined with an equal 
volume of Griess reagent ( 1% sulfanilamide, 0.1% napthylethylene diamine 
dihydrochloride, 2.5% H3PO4,) (Sigma Chemical Co.) and incubated at room temperature 
for 10 min. The ODjso was read using an automated plate reader (VMAX, Molecular 
Devices Corp., Menlo Park, CA). Nitrite concentration was calculated from a NaNO; 
standard curve.
Oxidative Burst Assav 
Induction of an oxidative burst was detected by a micro-fluorometric assay as 
previously described Briefly, the macrophage lines and/or clones were collected, 
resuspended to 2xlOVml in DPBS supplemented with 2% HIFBS, and plated at 100 
pl/well in a 96-well flat-bottom microtiter culture plate. Following the titration and 
addition of Zymosan A (Sigma Chemical Co.) or other triggering agent to the appropriate
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wells, DCFH-DA (2'-7'-dichIorodihydrofluorescin diacetate. Molecular Probes) was added 
to all wells at a final concentration of lOpM and incubated at 37°C, 5% CO; for 60 min. 
The fluorescence intensity was determined at 485^=10 nm excitation and 530±12.5 nm 
emission wavelengths using an automated fluorometer (FluoroCount, Packard Instrument 
Co, Inc., Meriden, CT) and the data expressed as relative fluorescent units (RFU).
Cell-ELISA
TNFa receptor expression on RAW 264.7 and C57B1/6J spleen derived 
macrophages was measured using an ELISA modified for use on adherent cell populations 
The cell cultures were washed three times with serum-free PBS and then fixed with 
0.05% glutaraldehyde (Sigma Chemical Co.) in PBS at 4°C for 30 min. Following 
fixation, the cells were washed three times with saline and covered with DPBS containing 
10% heat-inactivated horse serum (HS) and 5pg/ml human IgG (HGG). The 
DPBS/HS/HGG was then removed and replaced with 5 pg/ml of the appropriate primary 
antibody, anti-TNF-Rl, anti-TNF-R2, or normal rabbit IgG, diluted in DPBS/HS/HGG. 
The cells were incubated for 60 min at room temperature and then rinsed three times with 
saline. The cells were then incubated for 30 min at room temperature with an optimal 
concentration of a peroxidase conjugated donkey anti-rabbit Ig (Jackson ImmunoResearch 
Laboratories, Inc., West Grove, PA) diluted in DPBS/HS/HGG. Excess peroxidase 
conjugate was then removed by three washes with PBS containing 0.05% Tween 20 
followed by three washed with PBS alone. Antibody binding to the cells was detected by 
incubating the cells with 0.1 mg/ml 3,3',5,5'-tetramethylbenzidine (TMB, Sigma Chemical
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Co.) and 0.05 M phosphate-citrate buffer containing 0.03% sodium perborate (Sigma 
Chemical Co.) for 30 min at room temperature in the dark. The supernatant was then 
transferred to another microwell plate containing 50 pi 2 M suLfUric acid and the OD450 
was read on an automated plate reader.
FACS Analysis
For surface phenotyping of the macrophage clones, the clones were resuspended in 
PBS containing 0.1% Azide, 2% HIFBS, and 25pg/ml Human IgG. They were then 
incubated with the following panel o f antibodies: anti-CD4, anti-CD 8 , anti-ThB, anti-Mac- 
1, anti-F4/80, anti-CD40, anti-CD80, anti-CD8 6 , or biotinylated anti-la*’’* for 30 min at 
room temperature. The cells were rinsed with DPBS and incubated with either an FITC 
anti-rat or an FITC conjugated Neutralité Avidin for 30 min at room temperature in the 
dark. Following the incubation, the cells were washed with DPBS and analyzed on a 
FACStar Flow Cytometer (Becton Dickinson).
RT-PCR Analysis
Cells were plated at 1.2xl0®/well in a 6 -well plate (Falcon, Fisher Scientific). 
Following stimulation, the cells were treated with RNAzol (Gibco BRL) and the RNA 
extracted following the manufacturer’s instructions. The RNA was then reverse- 
transcribed into cDNA with MMLV-reverse transcriptase (Promega, Madison, WI). Two 
microliters of each cDNA sample were then used in a PCR reaction containing amplimer 
sets directed against G3PDH, IL-1(3, TNFa, and i-NOS (Clontech, Palo Alto, CA). The
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reactions were then subjected to an automated temperature cycling program consisting of 
the following: Step 1: 94°C for 45 sec, Step 2: 60°C for 45 sec. Step 3: 72°C for 1 min. 
Step 4: 72°C for 7 min, and Step 5: 4 °C hold. Steps 1-3 were repeated for 25 cycles for 
G3PDH and EL-ip, 30 cycles for iNOS, and 20 cycles for TNFa. Then, lOpl o f each 
PCR product was loaded onto a 1.5% ethidium bromide containing agarose gel and 
electrophoresed at -lOOV for 45-60 min. The gel was then visualized and photographed 
using Polaroid Type 665 Positive/Negative film (Fisher Scientific). The negatives were 
then scanned for densitometric analysis using the MCID-M4 Image Analysis software 
(Imaging Research, Inc., St. Catharines, Ontario). Relative induction for DL-ip, TNFa, 
and iNOS was determined by first normalizing each gene with the values obtained for the 
housekeeping gene, G3PDH. Values were then expressed as relative densitometric units.
Western Blot Analysis 
Cells were plated at 3xlOVwell in 24-well tissue culture plates (Coming, Fisher 
Scientific). Following stimulation, the cells were harvested in 50 pi boiling 2X 
electrophoresis sample buffer (125 mM Tris pH 6 .8 , 4% SDS, 10% glycerol, 0.006% 
bromphenol blue, 2 % P-mercaptoethanol). Samples were boiled for an additional 5 
minutes prior to protein separation by SDS-PAGE on 15% minigels Gels were then 
equilibrated in transfer buffer (48 mM Tris, pH 9.2, 39 mM glycine, 1.3 mM SDS, and 
20% methanol) for 15 minutes prior to transfer. Protein transfer to BioBlot-NC 
nitrocellulose membranes (Coming Costar Corp., Kennebunk, ME) was performed at 15V 
for 30 min using a Trans-Blot® SD Semidry Electrophoretic Transfer Cell (BioRad,
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Richmond, CA). Dried membranes were blocked with gentle agitation in PBS containing 
0.1% Tween 20 and 1% BSA (blocking buffer) for 30 min at 37°C . The membranes 
were then probed using a polyclonal rabbit anti-iNOS at 1:10,000 (Transduction 
Laboratories, Lexington, KY) in blocking buffer for 30 min at 37°C, washed for 10 min x 
2 washes in PBS containing 0.1% Tween-20 (PBS-T), followed by incubation with an 
HRP-conjugated donkey anti-rabbit IgG at 1:20,000 (Jackson ImmunoResearch 
Laboratories, Inc., West Grove, PA) in blocking buffer for an additional 30 min at 37°C, 
and then washed three times for 10 min each in PBS-T. Antibody bound proteins were 
detected using an ECL™ western blotting analysis system (Amersham Life Science, 
Arlington Heights, IL) and the membranes were exposed to Kodak BIOMAX ML x-ray 
film (Fisher Scientific). Membranes were then stripped (2% w/v SDS, 62.5 mM Tris-HCl, 
pH 6.7, 100 mM P-mercaptoethanol, 50°C for 30 min with occasional agitation), washed 
twice with PBS-T and placed in blocking buffer at 37°C for 30 min, and re-probed using a 
monoclonal mouse anti-P-actin at 1:5000 (Sigma) followed by a HRP-conjugated goat 
anti-mouse IgG at 1:40,000 (Jackson ImmunoResearch) to ensure loading of equivalent 
amounts of protein. The films were then scanned for densitometric analysis utilizing the 
UN-SCAN-IT™ gel automated digitizing system (Silk Scientific, Inc., Orem, UT) and the 
values expressed as relative densitometric units.
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CHAPTERS
ROLE OF TNFa RECEPTORS IN MACROPHAGE ACTIVATION
Effect o f Murine Versus Human TNFa in the Induction of Macrophage Nitric Oxide
Production
We and others have previously demonstrated that the induction of nitric oxide 
production requires synergistic signaling of the macrophages by both TNFa and IFNy 
83,84,99 Yo determine which TNFa receptor, TNF-Rl or TNF-R2, was the predominant 
receptor involved in the TNFa dependent activation of macrophage effector fimction, the 
specificity o f hTNFa for TNF-Rl was exploited. Macrophages generated fi"om spleen cell 
cultures were incubated with equivalent concentrations of either mTNFa or hTNFa in the 
presence of IFNy (100 U/ml) for 48 hr after which the culture supernatants were assayed 
for the accumulation of nitrite. Human TNFa was approximately 12-fold less effective in 
inducing NOj in these primary cultures of macrophages, such that induction of 11 pM 
nitric oxide (-50%  of maximal response observed) required 5 ng/ml hTNFa as compared 
to 0.4 ng/ml mTNFa (Figure 6A). In order to assess whether the activation state of the 
macrophages plays a role in the responsiveness to mTNFa versus hTNFa we compared 
the response patterns of C57B1/6J spleen derived macrophages to RAW 264.7, a 
macrophage cell line, and to C57B1/6J peritoneal elicited cells (PEC). Using 50% of the 
maximal response as a point for comparison, hTNFa was 5-fold less effective than 
mTNFa on RAW 264.7 (Figure 6B), 8-fold less effective than mTNFa on PEC (Figure 
6 C), and 12-fold less effective than mTNFa on spleen derived macrophages.
22
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Figure 6 . Effect of Murine TNFa vs. Human TNFa on the Induction of Macrophage 
Effector Function. Murine TNFa (closed circles) and Human TNFa (closed squares) 
were titrated onto (A) spleen-derived macrophages, (B) RAW 264.7, or (C) peritoneal 
elicited cells in the presence of 100 U/ml IFNy and cultured for 48 hr. Following 
incubation, culture supernatants were assayed for nitrite accumulation. The dotted line 
represents IFNy background. Data are presented as the arithmetic means of triplicate 
macrophage cultures ± SD and are representative of at least two separate experiments.
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Relative Expression o f TNF-Rl and TNF-R2 on RAW 264.7 and C57BL/6J
Macrophages
To compare the relative expression o f the two TNFa receptors on the 
macrophages used in this study cell-ELISAs were performed using purified anti-TNF-Rl 
and anti-TNF-R2 polyclonal antibodies. As depicted in Figure 7, the level of expression of 
TNF-Rl and TNF-R2 was approximately equal for RAW 264.7 (OD^^o 1.0 and 0.9, 
respectively). In contrast, spleen derived macrophages were found to have a significantly 
lower level of expression of TNF-Rl than TNF-R2 (OD^go o f 0.7 and 1.2, respectively). 
After adjusting the OD450 values by subtracting the normal rabbit IgG background, the 
ratio o f TNF-Rl to TNF-R2 expression on RAW 264.7 was approximately 1.1, while the 
ratio for the spleen derived macrophages was 0.58.
Antagonistic Effect of Anti-TNF-Receptor Antibodies on Macrophages
In order to define the roles of TNF-Rl and TNF-R2 in the induction of 
macrophage effector function, anti-TNF-Rl and anti-TNF-R2 were initially titrated onto 
cultures of splenic macrophages in the presence of mTNFa and IFNy. Anti-TNF-Rl 
reduced the ability of mTNFa to stimulate nitrite production in a dose-dependent fashion 
fi"om 0.3-2.5 pg/ml (Figure 8 A). Concentrations k 2.5 pg/ml of anti-TNF-Rl reduced the 
level of NO2 production induced by 3.9 ng/ml mTNFa to the background level of 3 pM 
which was obtained by stimulation with IFNy alone. Macrophages incubated overnight in 
the presence o f 5 pg/ml anti-TNF-Rl and stained for viability by trypan exclusion were 
found to be approximately 100% viable (data not shown), indicating that the anti-TNF-Rl
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Figure 7. Relative Expression of TNF-Rl and TNF-R2 on RAW 264.7 and C57BL/6J 
Macrophages. Each cell culture was incubated with 5 pg/ml of either anti-TNF-Rl, anti- 
TNF-R2, or normal rabbit IgG followed by incubation with an optimal concentration of a 
peroxidase conjugated donkey anti-rabbit Ig. Data are presented as the arithmetic mean of 
at least 2 separate experiments ± SD, each experiment was run in either duplicate or 
triplicate OD^ gg measurements.
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Figure 8 . Titration of Anti-TNF-Receptor Antibodies on Macrophages. Anti-TNF-Rl 
(A) and anti-TNF-R2 (B) were titrated onto cultures of spleen-derived macrophages in the 
presence of 3.9 ng/ml mTNFa and 100 U/ml IFNy and assessed for their ability to block 
the induction of nitric oxide following a 48 hr incubation period. Data are presented as 
the arithmetic means of triplicate macrophage cultures ± SD.
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was inhibiting function rather than causing macrophage cell death. Addition of 2.5 pg/ml 
anti-TNF-R2 to macrophages in the presence o f 3.9 ng/ml mTNFa resulted in a 40% 
reduction in the level of NOj production and this degree o f inhibition could not be 
increased by increasing the concentration of anti-TNF-R2 (Figure 8B).
To determine if the inhibitory effect of anti-TNF receptor antibodies could be 
overcome by increasing concentrations of TNFa, macrophages generated from spleen cell 
cultures were incubated with rlFNy and mTNFa in the presence of 5 pg/ml anti-TNF-Rl 
or 20 pg/ml anti-TNF-R2 for 48 hr after which the supernatants were assayed for nitrite 
accumulation (Figure 9A). Treatment with anti-TNF-R2 resulted in a partial inhibition of 
the mTNFa mediated induction of NO2 production whereas incubation with anti-TNF-Rl 
completely inhibited NO2 production. Increasing concentrations of mTNFa up to 12ng/ml 
(8,000 U/ml) could not supercede the blocking effect of anti-TNF-R2 (data up to 4 ng/ml 
are shown in Figure 9A). In contrast, when RAW 264.7 were subjected to the same 
experimental conditions as described above, increasing concentrations of mTNFa were 
able to overcome the inhibition by anti-TNF-R2 (Figure 9B). As was observed with 
primary cultures of macrophages, the addition of antibodies against TNF-Rl in the 
presence of mTNFa effectively blocked the production of nitric oxide.
Since TNF-Rl appeared to be the dominant receptor involved in the induction of 
macrophage effector function, several experimental approaches were attempted to 
determine whether ligation of TNF-Rl would induce production of NO2. Incubation of 
RAW 264.7 with IFNy and either 5 pg/ml anti-TNF-Rl followed by F(ab)'2 goat
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Figure 9. Antagonistic Effect of Anti-TNF-Receptor Antibodies on Macrophages.
Murine TNFcc was titrated onto cultures of (A) spleen-derived macrophages or (B) RAW
264.7 and incubated with 100  U/ml IFNy alone (closed circles), in the presence of 5 pg/ml 
anti-Rl (closed squares), or in the presence of 20 pg/ml anti-R2 (closed triangles) for a 
period o f 48 hr after which the supernatants were assayed for nitrite accumulation. The 
dotted line represents EFNy background. Data are presented as the arithmetic means of 
triplicate macrophage cultures ± SD and are representative of at least two separate 
experiments.
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anti-rabbit Ig or with anti-TNF-Rl immobilized on plastic did not induce significant nitric 
oxide production (data not shown).
Effect of IFNy and GM-CSF Pretreatment on the Induction of 
Macrophage Effector Function 
One possible explanation for the difference in response pattern between spleen 
derived macrophages and RAW 264.7 was the state of activation of the cells prior to 
exposure to TNFa. To investigate this hypothesis both spleen derived macrophages and 
RAW 264.7 were preincubated with either 100 U/ml IFNy, 400 U/ml GM-CSF, or media 
alone for 48 hours followed by stimulation with either mTNFa or hTNFa as previously 
described. Treatment with either IFNy or GM-CSF was capable of heightening the 
responsiveness of primary macrophages to both mTNFa and hTNFa (Figure 10AB,C). 
IFNy pretreatment resulted in a 40% and 170% increase in the maximal induction of NOj 
production in response to mTNFa and hTNFa, respectively (Figure lOB). Pretreatment 
with GM-CSF yielded a similar result such that the maximal induction o f NOj production 
in response to mTNFa and hTNFa were increased by 35% and 120%, respectively (Figure 
IOC). However, even with EFNy or GM-CSF priming, hTNFa was about 3-fold less 
effective than mTNFa in inducing nitric oxide in primary macrophages, which was 
nonetheless an improvement over the 12-fold difference seen with non-primed 
macrophages. Moreover, regardless of pretreatment, mTNFa yielded nitrite levels that 
were 20-40% in excess of those achievable with the superphysiologic concentration of 20 
ng/ml hTNFa.
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Figure 10. Effect of Cytokine Priming on the TNFa Mediated Induction of Macrophage 
Effector Function. Spleen-derived macrophages were preincubated with either media 
alone (A), 100 U/ml IFNy (B), or 400 U/ml GM-CSF (C) for 48 hours followed by 
stimulation with either mTNFa (closed circles) or hTNFa (closed squares) in the presence 
of 100 U/ml IFNy for an additional 48 hours. Following incubation, culture supernatants 
were assayed for nitrite accumulation. The dotted line represents IFNy background. Data 
are presented as the arithmetic means of triplicate macrophage cultures ± SD and are 
representative of at least two separate experiments.
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Unlike the spleen-derived macrophages, pretreatment of RAW 264.7 with EFNy or 
GM-CSF did not enhance the maximal responses elicited by either mTNFa or hTNFa 
(Figure 11A,B,C). EFNy pretreatment slightly downregulated the responsiveness o f RAW
264.7 14% and 23% for mTNFa and hTNFa, respectively (Figure 1 IB). Also in contrast 
to resting macrophage cultures, stimulation of RAW 264.7 with hTNFa, albeit at higher 
doses, was capable of eliciting levels of nitric oxide equivalent to those obtained by 
stimulation with mTNFa.
To determine if the effects noted in Figure 10 were due to modulation of surface 
expression of the two TNFa receptors, cell ELIS As were performed on spleen-derived 
macrophages which had been preincubated with IFNy, GM-CSF, or media alone for 48 
hr. Pretreatment of macrophages with either IFNy or GM-CSF had little effect on the 
relative expression of either TNF-Rl and TNF-R2 or on the ratio of TNF-Rl to TNF-R2 
expression (data not shown).
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
32
A  Nfecfia B. C GMCSF
m I N F  #
0 Ilf i-i iiiiif I 11iiii^
ICP
r  24
-  20
-  16
t- 12
-  8
- 4
ngW r ^ n i
Figure 11. Effect o f Cytokine Priming on the TNFa Mediated Induction of Effector 
Function in RAW 264.7. RAW 264.7 were preincubated with either media alone (A), 100 
U/ml IFNy (B), or 400 U/ml GM-CSF (C) for 48 hours followed by stimulation with 
either mTNFa (closed circles) or hTNFa (closed squares) in the presence of 100 U/ml 
IFNy for an additional 48 hours. Following incubation, culture supernatants were assayed 
for nitrite accumulation. The dotted line represents IFNy background. Data are 
presented as the arithmetic means of triplicate.
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CHAPTER 4
LPS STIMULATION OF TNFa-RECEPTOR DEFICIENT MACROPHAGES
Generation and Characterization of Wild-Tvpe and TNF-Receptor Negative
Macrophage Lines
Immortalized macrophage cell lines were established by infecting the bone marrow 
of TNFa-receptor negative (TRN) C57BL/6J mice and from wild type C57BL/6J mice 
(B6/J2) with the murine recombinant J2 retrovirus containing the w-myc and w-raf 
oncogenes as previously described The immortalized cell lines were subsequently 
cloned by limiting dilution and characterized for surface phenotype and macrophage 
effector fimctions. The B6/J2 (Figure 12A-D) and TRN (Figure 12E-H) cell lines were 
analyzed for the expression of surface molecules characteristic of macrophages. Both 
B6/J2 and TRN were found to express the macrophage markers F4/80, Mac-1 and CD 14, 
but did not express T (CD4, CD8 ) or B (ThB) cell markers (Figure 12 panels A, B, E and 
F). The immortalized lines were also assayed for expression of accessory/costimulatory 
molecules: la, CD40, CD80, and CD8 6  (Figure 12 panels C, D, G and H). The B6/J2 and 
TRN both expressed high levels of CD86  and moderate levels of la, CD40, and CD80.
The production of reactive oxygen and reactive nitrogen intermediates are two 
hallmark microbicidal effector mechansims employed by macrophages/monocytes \  
Therefore, the cell lines and clones were characterized for their ability to generate oxygen 
and nitrogen intermediates upon stimulation. The oxidative burst responses induced by
33
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Figure 12. Surface Phenotyping of Immortalized Macrophage Lines. Each o f the B6/J2 
(panel A-D) and TRN (panel E-H) macrophage clones were analyzed by flow cytometry. 
Approximately 1x10® cells were stained with a panel of antibodies reactive with the 
following determinants and compared to unstained controls: A and E, F4/80, Mac-1, CD4, 
CDS, and ThB; B and F, CD 14; C and G, la'’; D and H, CD40, CD80, CD8 6 . Histogram 
profiles of 10,000 cells from a representative clone for both B6/J2 and TRN are displayed.
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zymosan in the macrophage lines and clones were compared with those induced in RAW
264.7 and GM-CSF primed or unprimed spleen-derived macrophages. The oxidative 
response o f the B6/J2 line was nearly identical to that of GM-CSF primed spleen-derived 
macrophages (Figure 13 A) and was somewhat higher than the response o f  RAW 264.7 
(Figure 13B). The three wild-type clones tested (B6/J2.1, B6/J2.2, B6/J2.3) all responded 
with an intensity similar to the parent line (Figure 13B). Similarly, all the TNFa-receptor 
negative clones responded as well, or nearly as well, as the most responsive wild-type 
clone (B6/J2.1) (Figure 13C).
All o f the clones could be induced to produce nitric oxide upon stimulation with 
LPS plus IFNy (Figure 14). The B6/J2 line responded well to either LPS or TNFa, in the 
presence of IFNy, with a minimal response to either LPS or IFNy alone (Figure 14A). 
Each o f the wild-type clones responded in a similar fashion to the parent line (Fig 14B). 
The TNFa-receptor negative clones also produced nitric oxide in response to LPS plus 
IFNy, although there was variability in their responses to IFNy alone (Figure 14C). As 
expected, the TRN clones were completely unresponsive to stimulation by TNFa plus 
EFNy (Figure 14D), while the B6/J2 responded in a dose-dependent manner.
Immortalized macrophage lines deficient in either TNF-Rl (DC-1) or TNF-R2 (AC-2) 
were also characterized and found to be phenotypically and functionally indistinguishable 
fi'om the other macrophage lines (data not shown).
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Figure 13. Assessment of Functional Characteristics via Induction of Oxidative Burst.
The oxidative capacity of the B6/J2 macrophage line and clones was measured and 
compared to (A) spleen derived C57B16/J macrophages and (B) RAW 264.7. (C) The 
TRN macrophage clones were compared to a representative B6/J2 clone. Oxidative burst 
was induced and measured as described in Materials and Methods. The data, 
representative of at least two separate experiments, are presented as the arithmetic means 
of triplicate macrophage cultures ± SD and expressed as Relative Fluorescent Units.
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Figure 14. Assessment of Functional Characteristics via Induction o f Nitric Oxide 
Production. (A) Comparison of the B6/J2 parental line and RAW 264.7. (B) B6/J2 
clones compared to the parent B6/J2 line. (C) TRN clones compared to a representative 
B6/J2 clone. The cells were stimulated with media alone, lOU/ml EFNy, 100 ng/ml LPS, 
LPS + IFNy, or 5 ng/ml mTNFa + EFNy, as indicated, and cultured for 48h. (D) 
Titration o f mTNFa onto cultures of TRN clones and a representative B6/J2 clone in the 
presence of 10 U/ml IFNy and cultured for 48h. Following incubation, culture 
supernatants were assayed for nitrite accumulation. Data, representative o f at least two 
separate experiments, are presented as the arithmetic means of triplicate macrophage 
cultures ± SD (with IFNy background subtracted out in D).
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Involvement o f the TNFcc Autocrine Loop in the Induction of Macrophage NO 
Production Under Serum-Free Conditions 
The ability of the TRN to respond to low concentrations of LPS in the presence of 
serum indicated that autocrine stimulation by TNFa was not critical for CD14/LBP- 
mediated activation of nitric oxide generation. To determine if autocrine stimulation by 
TNFa was critical for LBP-independent activation of macrophages by LPS, B6/J2 and 
TRN were stimulated with up to 10 gg/ml LPS and 10 U/ml IFNy in serum free media. 
LPS stimulation of the B6/J2 in both the presence and absence of serum resulted in the 
production of NO although a higher concentration of LPS was required for optimal 
stimulation in the absence of serum (Figure 15). Conversely, stimulation o f the TRN in 
the absence of serum resulted in a very weak nitric oxide response that was ^SQVo of the 
response of TRN in the presence of serum and of the response of B6/J2 in the absence of 
serum (Figure 15).
Given the poor NO production by TRN in response to LPS in the absence of 
serum, it was important to determine if other LPS-mediated responses of TRN were 
equally affected. Hence, RNA harvested from both B6/J2 and TRN following a 4-hr 
stimulation with 0-10 p.g/ml LPS under serum-free conditions was analyzed via RT-PCR 
for the expression of iNOS, IL-lp, and TNFa (Figure 16). The PGR product bands were 
then scanned and analyzed by densitometry (Figure 17A-D). LPS stimulation resulted in a 
dose-dependent induction of EL-ip, TNFa, and iNOS for both B6/J2 and TRN. It is of 
interest that under serum-free conditions, LPS stimulation induced a higher level of iNOS 
RNA expression in TRN than in B6/J2 (Figure 17D). Supernatants from cultures treated
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Figure 15. Involvement of TNFa in the Induction o f Nitric Oxide Production Under 
Serum-Free Conditions. LPS was titrated onto cultures of B6/J2 (circles) and TRN 
(triangles) in the presence (closed symbols) and absence of serum (open symbols), 
cultured for 48h, and assayed for nitrite accumulation. Data are presented as the arithmetic 
means o f triplicate macrophage cultures ± SD.
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Figure 16. LPS Induced Gene Expression in Serum-Free Media I. RT-PCR was 
performed on RNA extracted from macrophages cultured in the absence of serum and 
treated with media alone or the indicated concentration of LPS for 4h. Upper lanes 1-8  
contain G3PDH PCR products, upper lanes 10-17 contain IL-ip PCR products, lower 
lanes 1-8 contain TNFa PCR products, and lower lanes 10-17 contain iNOS PCR 
products. Data is representative of at least two individual RNA isolations.
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Figure 17. LPS Induced Gene Expression in Serum-Free Media II. (A-D) Densitometric 
analysis was performed on PCR products of B6/J2 (open bars) and TRN (closed bars) 
presented in Figure 16. The data was normalized for G3PDH and expressed as Relative 
Densitometric Units.
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identically as those used for RT-PCR were collected and assayed for biologically active 
TNFa (Figure 18). LPS induced TNFa production in both B6/J2 and TRN in a dose- 
dependent manner, as indicated by the percent cytotoxicity o f L929, with 10 pg/ml LPS 
resulting in an equivalent production of TNFa by the two macrophage lines.
t
i
B6/J2 L Z )
J
Ug/ml LPS
Figure 18. Induction o f TNFa Production Under Serum-Free Conditions. LPS was 
titrated onto cultures of B6/J2 (open bars) and TRN (hatched bars) in serum-free media 
for 4h. Following incubation, the supernatants were assayed for TNFa bioactivity 
utilizing the L929 bioassay. Data, representative of at least two separate experiments, are 
presented as the arithmetic means of triplicate macrophage cultures.
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In an attempt to reconcile the relatively high iNOS mRNA expression with the low 
production of NO, lysates from TRN and B6/J2, stimulated with 10 pg/ml LPS under 
serum-free conditions for 0-48 hrs, were analyzed for the presence of iNOS protein 
(Figure 19). Stimulation of both B6/J2 and TRN resulted in a time-dependent increase in 
the amount of iNOS protein detected, regardless of the presence (Figure 19B) or absence 
(Figure 19 A) of IFNy. Densitometric analysis revealed that stimulation of TRN in the 
presence o f IFNy for 12 hr resulted in -60% less iNOS protein as compared to B6/J2 
with the difference decreasing to 20% by 48 hr (Figure 19D). In the absence of IFNy,
LPS stimulation o f TRN consistently resulted in 80-90% less iNOS protein production 
compared to B6/J2 (Figure 19C).
To confirm the critical role o f autocrine TNFa in LBP-independent mechanisms of 
macrophage activation, the B6/J2 were stimulated under serum-free conditions in the 
presence o f increasing concentrations of the soluble murine TNFa-receptor type 1. As 
shown in Figure 2 0 , soluble TNFa inhibitor reduced the amount of NO generated with 10 
pg/ml soluble TNFa-Rl effecting a 50% decrease in the nitric oxide response induced by 
1 pg/ml LPS and 10 U/ml IFNy.
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Figure 19. LPS Induced iNOS Protein Expression Under Serum-Free Conditions. B6/J2 
and TRN were stimulated for 0-48 hr with 10 pg/ml LPS alone (A) or in the presence of 
IFNy (B). Cell lysates were electrophoresed and subjected to western blot analysis. Data 
presented are representative of at least two individual experiments. C and D, 
Densitometric analysis of the gels presented above.
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Figure 20. Soluble Murine TNF-Rl Inhibition of B6/J2 Nitric Oxide Production. B6/J2 
macrophages were stimulated in serum-free media (close diamonds) with either 6  U/ml 
IFNy (closed triangle), 1 pg/ml LPS (closed square), or LPS + IFNy in the presence of 
increasing concentrations of soluble murine TNF-Rl (closed circle) for 48 h. Following 
incubation, culture supernatants were assayed for nitrite accumulation. Data, 
representative of at least two separate experiments, are presented as the arithmetic means 
of triplicate macrophage cultures ± SD.
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CHAPTERS
DISCUSSION
The induction o f macrophage effector function is, in part, a result o f  synergy 
between LPS and IFNy. LPS alone is capable of inducing the production and secretion of 
TNFa while IFNy not only enhances TNFa production, but also upregulates the surface 
expression of TNFa receptors allowing for the formation of a TNFa autocrine loop. 
TNFa, in the presence of IFNy, is capable of providing the necessary signals to induce the 
production of nitric oxide, a classic macrophage microbicidal and tumoricidal effector 
molecule *3-85.102,103 experiments described in this dissertation were designed not only 
to determine through which of the TNFa receptors the effects of TNFa are mediated, but 
also to assess the role of autocrine TNFa in the induction of macrophage effector 
function.
As demonstrated herein, the primary TNFa-mediated signals involved in the 
activation o f macrophage effector function are transduced through TNF-Rl insofar as 1) 
stimulation via TNF-Rl with hTNFa is sufficient for the induction of nitric oxide 
generation, and 2) addition of anti-TNF-Rl antibodies completely inhibits nitric oxide 
production. Although TNF-Rl is critical for the TNFa-mediated induction o f macrophage 
effector function, signaling through TNF-R2 contributes to the intensity o f the 
macrophage response such that addition o f anti-TNF-R2 partially inhibited macrophage 
activation.
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The cloning of the two murine TNFa receptors demonstrated that although TNF- 
R l had a similar afiSnity for both recombinant mTNFa and hTNFa, TNF-R2 showed 
affinity for only mTNFa, thus defining TNF-R2 as a species-specific receptor The 
ability of hTNFa to bind to TNF-Rl but not to TNF-R2 provides a model allowing 
separation of TNF-Rl mediated effects from TNF-R2 effects Using this model, 
TNF-Rl was found to mediate most of the biological effects of TNFa including initiation 
o f cellular cytotoxicity and apoptosis’°’^ \ enhancement of oxidative burst as
well as mediation of systemic shock during sepsis Our finding that hTNFa is
effective in the IFNy-dependent induction of nitric oxide in both cultured macrophages 
and a macrophage cell line indicates that ligation of TNF-Rl, by itself, is sufficient for 
TNFa-mediated induction of macrophage effector function. Furthermore, the ability of 
anti-TNF-Rl to abrogate the induction of a nitric oxide response by murine TNFa 
indicates that ligation of TNF-R2, by itself is not sufficient for TNFa mediated signaling 
o f macrophage activation. These observations on TNFa mediated signaling of mature 
macrophages conforms to the current body of evidence that TNF-Rl is the dominant 
receptor in TNFa mediated events.
In contrast to the abrogating effect of anti-TNF-Rl antibodies, treatment of 
macrophages with anti-TNF-R2 effected a partial inhibition of TNFa mediated signaling. 
The TNFa mediated generation of nitric oxide in RAW 264.7 appears to be dependent on 
TNF-R2 only at low doses of TNFa, such that 1) increasing concentrations of mTNFa 
overcome the partial inhibition elicited by antibody blocking of TNF-R2, and 2) 
stimulation of RAW 264.7 with high doses of hTNFa induces responses as intense as
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stimulation with mTNFa. These observations are consistent with the observed effects of 
hTNFa and anti-TNF-R2 on L929 fibroblasts. Based on the observations that hTNFa 
could effectively induce cellular cytotoxicity, albeit at higher concentrations than required 
for mTNFa, Tartaglia et al. proposed a "ligand passing" role for TNF-R2. This model 
suggests that TNF-R2 plays a role only at low TNFa concentrations and is based on the 
hypothesis that the higher affinity TNF-R2 rapidly associates and dissociates with TNFa, 
increasing the local concentration of TNFa at the cell surface which results in a more rapid 
association of TNFa with TNF-Rl. However, data have been accumulating recently that 
indicate the role of TNF-R2 may not be so simple.
The antagonistic effect of anti-TNF-R2 on spleen derived macrophages was quite 
different fi"om that seen with RAW 264.7. Whereas RAW 264.7 was only dependent on 
TNF-R2 at low TNFa concentrations, splenic macrophages exhibited a dependency on 
TNF-R2 over all concentrations of TNFa tested. The partial inhibition of mTNFa 
mediated macrophage activation by anti-TNF-R2 could be overcome in RAW 264.7 by 
increasing the mTNFa concentration, but was unaffected by increasing concentrations of 
mTNFa in splenic macrophages. This difference is also observed by comparing the 
differential response patterns elicited by mTNFa and hTNFa on the spleen derived 
macrophages (Fig. 6A) with the response patterns elicited by TNFa on RAW 264.7 (Fig. 
6B) and PEC (Fig. 6 C). In cultures of RAW 264.7 and PEC, high doses o f hTNFa can 
induce concentrations of nitric oxide equivalent to those induced by mTNFa, while in 
cultures of splenic macrophages, increasing doses of hTNFa are not able to achieve the 
level of nitric oxide generation elicited by mTNFa. Together these results suggest that the
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dependency on TNF-R2 in spleen-derived macrophages is greater than in RAW 264.7 or 
PEC.
One key difference between either RAW 264.7 or PEC and spleen-derived 
macrophages that may account for the varying dependence on TNF-R2 is their functional 
state. RAW 264.7, J774A.1, and elicited macrophages (as opposed to resident 
macrophages) have been shown to be in a "primed" state such that they constitutively 
produce cytokines such as IFNp, release significant quantities of prostaglandins, and can 
be induced to express significant effector function by LPS without exogenous IFNy In 
contrast, cultured macrophages appear to be more down-regulated or "resting" in that 
they do not produce nitric oxide in response to LPS alone and do not express cytokine 
mRNA or protein without stimulation |g established that responsiveness of
macrophages to a given stimulus depends on their state of activation It is therefore 
conceivable that the dependence on TNF-R2 in the TNFa mediated signaling of 
macrophage effector function may be related to the functional state of the macrophage. 
This current line o f thought is supported by our results which demonstrate that cytokine 
priming of spleen-derived macrophages decreased their dependence on TNF-R2 as 
compared to non-primed macrophages.
The results of Vandenabeele et al. on T cell apoptosis and our results on 
macrophage nitric oxide generation suggest a model for TNFa stimulated events which 
involves two distinct signals which can be mediated by each of the two TNFa receptors. 
Through triggering by agonistic mAbs and receptor-specific mutated proteins, 
Vandenabeele et al. demonstrated that the role of TNF-R2 in PC60 cells was not that o f a
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ligand passer, but instead, was that of an active participant in the intracellular signaling 
pathway leading to apoptosis. Consequently, the TNFa-mediated induction o f NO; in 
cultured macrophages may involve a signal delivered by TNF-R2 in spleen-derived 
macrophages which amplifies (or synergizes) with the signal transduced via TNF-Rl, 
culminating in the activation of nitric oxide synthase. While cytokine priming o f splenic 
macrophages was capable of enhancing the maximal induction o f nitric oxide production in 
response to both species of TNFa and increasing the autonomy o f TNF-Rl, priming failed 
to enhance expression of either TNF-Rl or TNF-R2. This suggests that GM-CSF or 
IFNy can initiate signaling pathways which either bypass signaling via TNF-R2 or provide 
signals similar to those mediated through TNF-R2.
The mechanism by which TNF-Rl and TNF-R2 signal the induction of nitric oxide 
synthase is still unclear. Both VanArsdale and Ware and Damay et al. have 
demonstrated that a serine/threonine kinase associates with the cytoplasmic region of 
TNF-Rl and is subsequently activated by TNFa binding. Rothe et al. have identified a 
group of putative signal transducers associated with the cytoplasmic domain of the hTNF- 
R2 termed TNFa receptor-associated factor 1 (TRAFl) and TRAF2 It has also been 
shown that maximal expression of the macrophage nitric oxide synthase is dependent upon 
two discrete regulatory regions upstream from the putative TATA box “ . Region I 
contains LPS-related response elements, including NF-IL6  and a binding site for NF-kB, 
while region II contains motifs for binding EFN-related transcription factors. Whether 
both TNF-Rl and TNF-R2 activate transcription factors which may bind to region I has 
yet to be determined.
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The second aim of this dissertation was to better understand the contribution of 
autocrine TNFa in the induction of macrophage effector function. As demonstrated 
herein, TNFa autocrine stimulation was critical for the LPS-mediated induction of 
macrophage NO production via the LBP-independent pathway insofar as 1) the NO 
response of macrophages which lack both types of TNFa receptors was significantly 
impaired when stimulated with LPS in the absence of serum whereas wild-type 
macrophages were unaffected (Fig 15) and 2) LBP-independent LPS stimulation o f wild- 
type macrophages in the presence of a soluble TNFa inhibitor resulted in a dose- 
dependent reduction in nitric oxide generation (Fig 19).
The macrophage lines developed for use in this study were generated via selective 
immortalization with retroviral vectors carrying the v-myc and v-raf oncogenes The 
immortalized lines/clones were phenotypically and functionally indistinguishable from 
either RAW 264.7 or primary spleen-derived macrophages. Not only did the immortalized 
lines and clones express the specific macrophage markers (Mac-1, F4/80, CD 14) but they 
also displayed characteristic accessory markers (la, CD40, CD80, CD8 6 ) providing an 
excellent model for studying macrophage interactions. Additionally, both wild-type B6/J2 
and the TNF-receptor deficient TRN were capable of producing NO in response to LPS 
and of generating an oxidative burst in response to stimulation with zymosan in a manner 
similar to that o f RAW 264.7 and splenic macrophages.
CD14 has been well characterized as a receptor for LPS CD 14 mediated
macrophage activation is a serum-dependent event, in that the circulating glycoprotein 
LBP facilitates the binding of LPS by CD 14 Furthermore, antibodies directed against
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CD 14 could only inhibit the response of a human monocytic cell line to LPS in the 
presence o f serum As shown by the current study, induction of macrophage NO 
production in the presence of serum requires 100-fold less LPS than that needed for 
similar production of NO in the absence of serum. Thus, the serum-independent, LBP- 
independent pathway appears to involve a low affinity receptor, since higher 
concentrations of LPS 1 pg/ml) were required to elicit a response.
Studies on CD14-knockout mice have elucidated the CD 14-independent 
mechanisms of LPS activation and have revealed differential activation of macrophage 
functions by CD 14-dependent and CD 14-independent pathways. Perera et al.“ '* recently 
characterized a CD 14-independent pathway of LPS activation which resulted in the 
production of TNFa and EL-ip with minimal induction of interferon-inducible protein (IP- 
10), whereas stimulation via CD 14 resulted in the induction of all three. Consistent with 
results of Perera et al., the current study shows that LBP-independent LPS activation 
results in the induction of IL-ip, TNFa, and iNOS gene expression in both wild-type and 
TNF-receptor deficient macrophages. The dose-dependent induction of these genes 
corresponded to the significant production of end product with the exception of NO 
production by TRN. Although the LBP-independent LPS stimulation of TRN induced 
equivalent if not greater levels of mRNA for iNOS as compared to B6/J2, the amount of 
LNOS protein produced and NO released was markedly reduced. Taken together, these 
data suggest autocrine TNFa plays a critical role in post-transcriptional regulation of NO 
production by macrophages stimulated via LBP-independent pathways.
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Previous studies have shown that iNOS is highly subject to post-transcriptional 
regulation"^"^'"^. Vodovotz et al.“  ^linked TGF-P to the suppression o f iNOS 
expression through enhanced degradation of iNOS mRNA, impaired translation, and 
accelerated protein degradation. Our data cannot be explained by autocrine TGF-P 
control of iNOS since the levels of TGF-P, as detected by ELISA, were significantly lower 
in TRN as compared to B6/J2 following stimulation with 10 pg/ml LPS under serum-free 
conditions either with or without IFNy for 48 hr (data not shown). A second, more likely 
scenario was suggested by the results of Walker et al."^ in which increased iNOS 
degradation was ascribed to the proteolytic action of the cysteine protease calpain. 
Applying their findings to our own observations it is conceivable that the LPS-mediated 
induction of macrophage nitric oxide production in the absence of LBP requires the 
activation o f a calpain inhibitor that appears to be autocrine TNFa-dependent. This 
scenario would thus provide a plausible explanation for the lower levels of iNOS protein 
detected in the LBP-independent LPS stimulation of TRN as compared to B6/J2.
The differential signaling of macrophage function observed in CD 14 -/- 
macrophages and in TRN macrophages is intriguing. One explanation is that, in both 
cases, LPS is binding to, and signaling via, an as yet unidentified low affinity LPS receptor 
that initiates a signal cascade similar, but not identical, to that initiated through the CD14- 
associated signaling complex An alternative explanation is suggested by the recent 
report that the CD14-associated signaling molecule(s) is a member of the Toll-like 
receptor (TLR) family of which 5 homologues have been identified Binding of LPS to 
TLR-2 evidently requires LBP facilitation and appears to be slightly enhanced by CD 14.
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Although it is not yet clear if LPS or LBP/LPS complexes associate with the other 
members o f the TLR family, the binding of different TLR proteins by LPS /LBP and CD 14 
would offer an explanation for the observed differential loss of signaling under either 
CD 14-independent or LBP-independent conditions.
In summary, this dissertation has 1) characterized the roles of the two TNFa 
receptors in the TNFa-mediated activation of macrophages and 2) described a critical role 
for autocrine TNFa in serum-independent LPS-induced macrophage activation. We have 
provided direct evidence indicating that TNFa-mediated macrophage activation primarily 
utilizes TNF-Rl for the induction of nitric oxide. In addition, we have also demonstrated 
that the role of TNF-R2 is not limited to sequestration and facilitation of TNFa for TNF- 
Rl signaling, but rather appears to be an active participant in the induction of nitric oxide. 
Secondly, we have identified a critical role for autocrine TNFa in the post-transcriptional 
regulation of nitric oxide synthase in macrophages stimulated with LPS in the absence of 
serum. This would suggest that following stimulation with LPS in the absence of LBP, 
autocrine TNFa-mediated initiation of some unidentified signaling pathway is necessary 
for optimal iNOS activity. The mechanism of TNFa-mediated post-transcriptional 
regulation of iNOS has yet to be elucidated.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
REFERENCES
55
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
56
REFERENCES
1. Auger MJ, Ross JA. The biology of the macrophage. In: Lewis CE, McGee JO,
editors. The Macrophage. New York: Oxford University Press; 1992. p 3-
74.
2. Adams DO, Hamilton TA. The cell biology of macrophage activation. Annu Rev
Immunol 1984;2:283-318:283-318.
3. Kamovsky ML. Metchnikofif in Messina: a century o f studies on phagocytosis. N
Engl J Med 1981 May 7;304(19): 1178-80.
4. Stout RD, Suttles J. Macrophage Maturation and Function. T-Cell Signaling of
Macrophage Activation: Cell Contact-Dependent and Cytokine Signals. 
Austin: R.G. Landes Company; 1995. p 21-61.
5. Lyons CR, Orloff GJ, Cunningham JM. Molecular cloning and functional expression
of an inducible nitric oxide synthase from a murine macrophage cell line. J 
Biol Chem 1992 Mar 25;267(9):6370-4.
6 . Xie QW, Cho HI, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso
T, Nathan C. Cloning and characterization of inducible nitric oxide synthase 
from mouse macrophages. Science 1992 Apr 10;256(5054):225-8.
7. Palmer RM, Rees DD, Ashton DS, Moncada S. L-arginine is the physiological
precursor for the formation of nitric oxide in endothelium-dependent 
relaxation. Biochem Biophys Res Commun. 1988 Jun 30;153(3):1251-6.
8 . Hibbs JBJ, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine
deiminase and imino nitrogen oxidation to nitrite. Science 1987 Jan 
23;235(4787):473-6.
9. Drapier JC, Wietzerbin J, Hibbs JBJ. Interferon-gamma and tumor necrosis factor
induce the L-arginine- dependent cytotoxic effector mechanism in murine 
macrophages. Eur J Immunol 1988 Oct;18(10):1587-92.
10. Lorsbach RB, Murphy WJ, Lowenstein CJ, Snyder SH, Russell SW. Expression of
the nitric oxide synthase gene in mouse macrophages activated for tumor cell 
killing. Molecular basis for the synergy between interferon-gamma and 
lipopolysaccharide. J Biol Chem 1993 Jan 25;268(3): 1908-13.
11. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW,
Murphy WJ. Macrophage nitric oxide synthase gene: two upstream regions 
mediate induction by interferon gamma and lipopolysaccharide. Proc Natl 
Acad Sci U S A 1993 Oct 15;90(20);9730-4.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
57
12. Liew F Y, Cox FE. Nonspecific defence mechanism: the role o f nitric oxide.
Immunol Today 1991 Mar;12(3):A17-A21
13. Kolb H, Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity.
Immunol Today 1992 May;13(5):157-60.
14. Durum SK, Schmidt JA, Oppenheim JJ. Interleukin 1: an immunological perspective.
Annu Rev Immunol 1985;3:263-87;263-87.
15. Dinarello CA. An update on human interleukin-1; from molecular biology to clinical
relevance. J Clin Immunol 1985 Sep;5(5):287-97.
16. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol
1989;44:153-205:153-205.
17. Pinson DM, LeClaire RD, Lorsbach RB, Parmely MJ, Russell SW. Regulation by
transforming growth factor-beta 1 of expression and function o f the receptor 
for IFN-gamma on mouse macrophages. J Immunol 1992;149:2028-34.
18. Bermudez LE. Production of transforming growth factor-beta by Mycobacterium
avium-infected human macrophages is associated with unresponsiveness to 
IFN-gamma. J Immunol 1993 ;(150): 183 8-45.
19. Moore KW, O'Garra A, de Waal M, Vieira P, Mosmann TR. Interleukin-10. Annu
Rev Immunol 1993;11:165-90:165-90.
20. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin
10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory 
role of IL-10 produced by monocytes. J Exp Med 1991 Nov 
1;174(5): 1209-20.
21. de Waal Malefyt R, Yssel H, Roncarolo MG, Spits H, de Vries JE. Interleukin-10.
Curr Opin Immunol 1992 Jun;4(3):314-20.
22. Cunha FQ, Moncada S, Liew FY. Interleukin-10 (IL-10) inhibits the induction of
nitric oxide synthase by interferon-gamma in murine macrophages. Biochem 
Biophys Res Commun. 1992 Feb 14;182(3):1155-9.
23. Marsh CB, Wewers MD. Cytokine-induced interleukin-1 receptor antagonist release
in mononuclear phagocytes. Am J Respir Cell Mol Biol 1994 
May;10(5):521-5.
24. Marsh CB, Moore SA, Pope HA, Wewers MD. IL-lra suppresses endotoxin-
induced IL-1 beta and TNF-alpha release from mononuclear phagocytes.
Am J Physiol 1994 Jul;267(l Pt 1):L39-L45
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
5 8
25. Tian L, Noelle RJ, Lawrence DA. Activated T cells enhance nitric oxide production
by murine splenic macrophages through gp39 and LFA-I. Eur J Immunol 
1995 Jan;25(l):306-9.
26. Tao X, Stout RD. T cell-mediated cognate signaling of nitric oxide production by
macrophages. Requirements for macrophage activation by plasma 
membranes isolated from T cells. Eur J Immunol 1993 Nov;23(l 1):2916-
21 .
27. Wagner DHJ, Stout RD, Suttles J. Role of the CD40-CD40 ligand interaction in
CD4+ T cell contact- dependent activation of monocyte interleukin-1 
synthesis. Eur J Immunol 1994 Dec;24(12);3148-54.
28. Roy M, Waldschmidt T, Arufifo A, Ledbetter JA, Noelle RJ. The regulation of the
expression of gp39, the CD40 ligand, on normal and cloned CD4 + T cells. J 
Immunol 1993 Sep 1;151(5):2497-510.
29. Castle BE, Kishimoto K, Steams C, Brown ML, Kehry MR. Regulation of
expression of the ligand for CD40 on T helper lymphocytes. J Immunol 
1993 Aug 15;151(4):1777-88.
30. Stout RD, Suttles J. The many roles of CD40 in cell-mediated inflammatory
responses. Immunol Today 1996 Oct; 17(10);487-92.
31. Callard RE, Armitage RJ, Fanslow WC, Spriggs MK. CD40 ligand and its role in X-
linked hyper-IgM syndrome. Immunol Today 1993 Nov;14(l l):559-64.
32. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC. Human B cell proliferation
and Ig secretion induced by recombinant CD40 ligand are modulated by 
soluble cytokines. J Immunol 1993 May l;150(9):3671-80.
33. Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor
pair for thymus- dependent B-cell activation. Immunol Today 1992 
Nov;13(ll);431-3.
34. Hollenbaugh D, Ochs HD, Noelle RJ, Ledbetter JA, Arufrb A. The role of CD40
and its ligand in the regulation of the immune response. Immunol Rev 1994 
Apr; 138:23-37:23-37.
35. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJ, Claassen E.
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis 
and multiple sclerosis. Proc Natl Acad Sci U S A 1996 Mar 19;93(6):2499- 
504.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
59
36. Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, Janeway
CAJ, Flavell RA. Requirement for CD40 ligand in costimulation induction, T 
cell activation, and experimental allergic encephalomyelitis. Science 1996 
Sep 27;273(5283): 1864-7.
37. Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in
vivo level. FEBS Lett 1991 Jul 22;285(2);199-212.
38. Vilcek J, Lee TH. Tumor necrosis factor. New insights into the molecular
mechanisms of its multiple actions. J Biol Chem 1991 Apr 
25;266(12):7313-6.
39. Beutler B, Cerami A. The biology of cachectin/TNF—a primary mediator of the host
response. Annu Rev Immunol 1989;7:625-55.
40. Lee JD, Kravchenko V, Kirkland TN, Han J, Mackman N, Moriarty A, Leturcq D,
Tobias PS, Ulevitch RJ. Glycosyl-phosphatidylinositol-anchored or integral 
membrane forms of CD 14 mediate identical cellular responses to endotoxin. 
Proc Natl Acad Sci U S A 1993 Nov l;90(21):9930-4.
41. Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL. Expression of
surface lymphotoxin and tumor necrosis factor on activated T, B, and natural 
killer cells. J Immunol 1992 Dec 15;149(12):3881-8.
42. Lisby S, Muller KM, Jongeneel CV, Saurat JH, Hauser C. Nickel and skin irritants
up-regulate tumor necrosis factor-alpha mRNA in kératinocytes by different 
but potentially synergistic mechanisms. Int Immunol 1995 Mar;7(3):343-52.
43. Bissonnette EY, Chin B, Befus AD. Interferons differentially regulate histamine and
TNF-alpha in rat intestinal mucosal mast cells. Immunology 1995 
Sep;86(l):12-7.
44. Zhou LJ, Tedder TF. A distinct pattern of cytokine gene expression by human
CD83+ blood dendritic cells. Blood 1995 Nov 1;86(9):3295-301.
45. Lin JX, Vilcek J. Tumor necrosis factor and interleukin-1 cause a rapid and transient
stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J Biol 
Chem 1987 Sep 5;262(25): 11908-11.
46. Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MAT, Shepard HM.
Recombinant human tumor necrosis factor-alpha; effects on proliferation of 
normal and transformed cells in vitro. Science 1985 Nov 22;230(4728):943-
5.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
60
47. Gamble JR, Smith WB, Vadas MA, Beutler B. TNF Modulation o f Endothelial and
Neutrophil Adhesion. [Anonymous] Tumor Necrosis Factors: The 
Molecules and Their Emerging Role in Medicine. New York: Raven Press; 
1992. p 65-86.
48. Schutze S, Machleidt T, Kronke M. Mechanisms of tumor necrosis factor action.
Semin Oncol. 1992 Apr; 19(2 Suppl 4): 16-24.
49. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr
WJ, Aggarwal BB, Goeddel DV. Human tumour necrosis factor: precursor 
structure, expression and homology to lymphotoxin. Nature 1984 Dec 
20;312(5996):724-9.
50. Shirai T, Yamaguchi H, Ito H, Todd CW, Wallace RB. Cloning and expression in
Escherichia coli of the gene for human tumour necrosis factor. Nature 1985 
Feb28;313(6005):803-6.
51. Gruss HJ, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the
pathology of malignant lymphomas. Blood 1995 Jun 15;85(12):3378-404.
52. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, WoLfson MF, Castner BJ,
Stocking KL, Reddy P, Srinivasan S, and others. A metalloproteinase 
disintegrin that releases tumour-necrosis factor- alpha from cells. Nature 
1997 Feb 20;385(6618):729-33.
53. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay
WC, Didsbury JR, Hassler D, and others. Cloning of a disintegrin 
metalloproteinase that processes precursor tumour-necrosis factor-alpha 
[published erratum appears in Nature 1997 Apr 17;3 86(6626):73 8 ]. Nature 
1997 Feb 20;385(6618):733-6.
54. Yamagishi J, Kawashima H, Matsuo N, Ohue M, Yamayoshi M, Fukui T, Kotani H,
Furuta R, Nakano K, Yamada M. Mutational analysis o f structure—activity 
relationships in human tumor necrosis factor-alpha. Protein Eng. 1990 
Aug;3(8):713-9.
55. Van Ostade X, Tavemier J, Prange T, Fiers W. Localization of the active site of
human tumour necrosis factor (hTNF) by mutational analysis [published 
erratum appears in EMBO J 1992 Aug;l 1(8):3156]. EMBO J 1991 
Apr;10(4):827-36.
56. Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol Today 1992
May; 13(5): 151-3.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
61
57. Damay BG, Aggarwal BB. Early events in TNF signaling: a story o f associations
and dissociations. JLeukocBiol 1997 May;61(5):559-66.
58. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily o f cellular and
viral proteins: activation, costimulation, and death. Cell 1994 Mar 
25;76(6):959-62.
59. Armitage RJ. Tumor necrosis factor receptor superfamily members and their ligands.
Curr Opin Immunol 1994 Jun;6(3):407-13.
60. Ware CF, VanArsdale S, VanArsdale TL. Apoptosis mediated by the TNF-related
cytokine and receptor families. J Cell Biochem 1996 Jan;60(l):47-55.
61. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY,
Goeddel DV. Cloning and expression of cDNAs for two distinct murine 
tumor necrosis factor receptors demonstrate one receptor is species specific. 
Proc Natl Acad Sci U S A 1991 Apr l;88(7):2830-4.
62. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MAJ, Goeddel DV. The
two different receptors for tumor necrosis factor mediate distinct cellular 
responses. Proc Natl Acad Sci U S A 1991 Oct 15;88(20):9292-6.
63. Wiegmann K, Schutze S, Kampen E, Himmler A, Machleidt T, Kronke M. Human
55-kDa receptor for tumor necrosis factor coupled to signal transduction 
cascades. J Biol Chem 1992 Sep 5;267(25): 17997-8001.
64. Ranheim EA, Kipps TJ. Tumor necrosis factor-alpha facilitates induction o f CD80
(B7-1) and CD54 on human B cells by activated T cells: complex regulation 
by IL-4, IL-10, and CD40L. Cell Immunol 1995 Apr l;161(2):226-35.
65. Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family o f putative signal
transducers associated with the cytoplasmic domain o f the 75 kDa tumor 
necrosis factor receptor. Cell 1994 Aug 26;78(4):681-92.
6 6 . Ehrke MJ, Ho RL, Hori K. Species-specific TNF induction of thymocyte
proliferation. Cancer Immunol Immunother. 1988;27(2):103-8.
67. Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M,
Lesslauer W, Tavemier J, Brouckaert P, Fiers W. Human TNF mutants with 
selective activity on the p55 receptor. Nature 1993 Jan 2 1 ;361 (6409):266-
9.
6 8 . Heller RA, Song K, Fan N, Chang DJ. The p70 tumor necrosis factor receptor
mediates cytotoxicity. Cell 1992 Jul 10;70(l):47-56.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
62
69. Wong GH, Tartaglia LA, Lee MS, Goeddel DV. Antiviral activity o f tumor necrosis
factor is signaled through the 55- kDa type ITNF receptor. J Immunol 
1992 Nov I5;149(10):3350-3.
70. Grell M, Zimmermann G, Hulser D, Pfizenmaier K, Scheurich P. TNF receptors
TR60 and TR80 can mediate apoptosis via induction o f distinct signal 
pathways. J  Immunol 1994 Sep l;I53(5):I963-72.
71. Higuchi M, Aggarwal BB. Differential roles of two types of the TNF receptor in
TNF-induced cytotoxicity, DNA fragmentation, and differentiation. J 
Immunol 1994 Apr 15; 152(8):4017-25.
72. Barbara JA, Smith WB, Gamble JR, Van Ostade X, Vandenabeele P, Tavemier J,
Fiers W, Vadas MA, Lopez AF. Dissociation of TNF-alpha cytotoxic and 
proinflammatory activities by p55 receptor- and p75 receptor-selective TNF- 
alpha mutants. EMBO J 1994 Feb 15;13(4):843-50.
73. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A,
Zinkemagel R, Steinmetz M, Bluethmann H. Mice lacking the tumour 
necrosis factor receptor 1 are resistant to TNF- mediated toxicity but highly 
susceptible to infection by Listeria monocytogenes. Nature 1993 Aug 
26;364(6440):798-802.
74. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A,
Wiegmann K, Ohashi PS, Kronke M, Mak T. Mice deficient for the 55 kD 
tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb 
to L. monocytogenes infection. Cell 1993;73:457-67.
75. Taga T, Kishimoto T. Cytokine receptors and signal transduction. FASEB J 1992
Dec;6(15):3387-96.
76. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994 Jan
28;76(2):253-62.
77. Fields S, Song O. A novel genetic system to detect protein-protein interactions.
Nature 1989 Jul 20;340(6230):245-6.
78. Arenzana-Seisdedos F, Mogensen SC, Vuillier F, Fiers W, Virelizier JL. Autocrine
secretion of tumor necrosis factor under the influence o f interferon-gamma 
amplifies HLA-DR gene induction in human monocytes. Proc Natl Acad Sci 
U S A  1988 Aug;85(16):6087-91.
79. Schultz RM. Autocrine versus lymphocyte-dependent mechanisms for macrophage
activation. Cell Signal. 1991;3(6):515-22.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
63
80. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine,
and autocrine control of inflammatory responses. J Cell Biol 1988 
Oct; 107(4): 1269-77.
81. Stout RD. Macrophage activation by T cells: cognate and non-cognate signals. Curr
Opin Immunol 1993 Jun;5(3):398-403.
82. Vogel SN, Havell EA. Differential inhibition of lipopolysaccharide-induced
phenomena by anti-tumor necrosis factor alpha antibody. Infect Immun 
1990 Jul;58(7):2397-400.
83. Langermans JA, Van der Hulst ME, Nibbering PH, Hiemstra PS, Fransen L, Van
Furth R. IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity 
in murine peritoneal macrophages is mediated by endogenous tumor necrosis 
factor-alpha. J Immunol 1992 Jan 15;148(2):568-74.
84. Munoz-Femandez MA, Fernandez MA, Fresno M. Synergism between tumor
necrosis factor-alpha and interferon-gamma on macrophage activation for the 
killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent 
mechanism. Eur J Immunol 1992 Feb;22(2):301-7.
85. Stout RD, Suttles J. Evidence for involvement of TNFa in the induction phase and
IFNP in the effector phase of antiproliferative activity of splenic 
macrophages. Cell Immunol. 1992;139:363-74.
8 6 . Springer TA, Galfi’e G, Secher DS, Milstein C. Monoclonal xenogeneic antibodies to
murine cell surface antigens: identification of novel leukocyte differentiation 
antigens. Eur J Immunol. 1978;8:539-51.
87. Ozato K, Sachs DH. Monoclonal antibodies to mouse MHC antigens, m.
Hybridoma antibodies reacting to antigens of the H-2'’ haplotype reveal 
genetic control of isotype expression. J Immunol 1981;126:317-21.
8 8 . Dialynas DP, Quan ZS, Wall KA, Pierres A, Quintans J, Loken MR, Pierres M, Fitch
FW. Characterization of the murine T cell surface molecule, designated 
L3T4, identified by monoclonal antibody GK 1.5: similarity of L3T4 to the 
human Leu3/T4 molecule. J Immunol 1983; 131:2445-.
89. Ledbetter JA, Herzenberg LA. Xenogeneic monoclonal antibodies to mouse
lymphoid differentiation antigens. Immunol Rev 1979;47:63-90.
90. Eckhardt LA, Herzenberg LA. Monoclonal antibodies to ThB detect close linkage of
Ly-6  and a gene regulating ThB expression. Immunogenetics 1980; 11:275- 
81.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
64
91. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the
mouse macrophage. Eur J Immunol 1981;11(10);805-15.
92. Stout RD. Cytostatic activity of in vitro generated macrophages. Evidence for a
prostaglandin-independent reversible cytostatic mechanism. Cell Immunol 
1985;96:83-103.
93. Cox GW, Mathieson BJ, Gandino L, Blasi E, Radzioch D, Varesio L. Heterogeneity
of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus 
infection of bone marrow or fetal liver. J Natl Cancer Inst 1989;81:1492-6.
94. Drysdale BE, Zacharchuk CM, Shin HS. Mechanism of macrophage-mediated
cytotoxicity: production of a soluble cytotoxic factor. J Immunol 
1983;131:2362-7.
95. Ding AH, Nathan CF, Stuehr DJ. Release o f reactive nitrogen intermediates and
reactive ojQ^gen intermediates fi'om mouse peritoneal macrophages. 
Comparison of activating cytokines and evidence for independent 
production. J Immunol 1988;141:2407-12.
96. Wan CP, Myung E, Lau BHS. An automated micro-fluorometric assay for
monitoring oxidative burst activity of phagocytes. J Immunol Methods 
1993;159:131-8.
97. Nibbering PH, Van de Gevel IS, Van Furth R. A cell-ELIS A for the quantification
of adherent murine macrophages and the surface expression of antigens. J 
Immunol Methods 1990; 131:25-32.
98. Laemmli UK. Cleavage of structural proteins during the assembly o f the head o f
bacteriophage T4. Nature 1970 Aug 15;227:680-5.
99. Stout RD, Suttles J. The two-signal paradigm for activation o f macrophage effector
function. T-Cell Signaling of Macrophage Activation: Cell Contact- 
Dependent and Cytokine Signals. Austin, TX: R.G. Landes Company; 1995. 
p 63-92.
100. Blasi E, Mathieson BJ, Varesio L, Cleveland JL, Borchert PA, Rapp UR. Selective
immortalization of murine macrophages fi'om fi-esh bone marrow by a 
rafimyc recombinant murine retrovirus. Nature 1985 Dec 
19;318(6047):667-70.
101. Ruggiero V, Tavemier J, Fiers W, Baglioni C. Induction o f the synthesis o f tumor
necrosis factor receptors by interferon-gamma. J Immunol 1986 Apr 
l;136(7):2445-50.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
65
102. Green SJ, Nacy CA, Schreiber RD, Granger DL, Crawford RM, Meltzer MS,
Fortier AH. Neutralization of gamma interferon and tumor necrosis factor 
alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and 
protection against Francisella iularensis infection in Mycobacterium bovis 
BCG-treated mice. Infect Immun 1993;61:689-98.
103. Green SJ, Nacy CA, Meltzer MS. Cytokine-induced synthesis o f nitrogen oxides in
macrophages: a protective host response to leishmania and other 
intracellular pathogens. J Leukocyte Biology 1991;50:93-103.
104. Tartaglia LA, Pennica D, Goeddel DV. Ligand passing: the 75-kDa tumor necrosis
factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF 
receptor. JBiolChem 1993;268:18542-8.
105. Stout RD, Suttles J. Functional characteristics of in vitro generated macrophages. A
transient refractory state preceeds re-inducibility of a spatially restricted, 
possibly contact dependent cytostatic mechanism. Cell Immunol 
1987;105:33-45.
106. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth
factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci 
1993;685:713-39.
107. Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J, Fiers W. Both TNF
receptors are required for TNF-mediated induction of apoptosis in PC60 
cells. J Immunol 1995;154:2904-13.
108. Van Arsdale TL, Ware CF. TNF receptor signal transduction ligand-dependent
stimulation of a serine protein kinase activity associated with (CD 120a) 
TNFR60. J Immunol 1994;153:3043-50.
109. Damay BG, Reddy SAG, Aggarwal BB. Identification of a protein kinase associated
with the cytoplasmic domain of the p60 tumor necrosis factor receptor. J 
Biol Chem 1994;269:20299-304.
110. Golenbock DT, Bach RR, Lichenstein H, Juan TS, Tadavarthy A, Moldow CF.
Soluble CD 14 promotes LPS activation of CD 14-deficient PNH monocytes 
and endothelial cells. J  Lab Clin Med 1995 May;125(5):662-71.
111. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD 14, a receptor for
complexes of lipopolysaccharide (LPS) and LPS binding protein [see 
comments]. Science 1990 Sep 21;249(4975): 1431-3.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
66
112. Tobias PS, Soldau K, Kline L, Lee JD, Kato K, Martin TP, Ulevitch RJ. Cross-
linking of lipopolysaccharide (LPS) to CD 14 on THP-1 cells mediated by 
LPS-binding protein. J  Immunol 1993 Apr 1;150(7):3011-21.
113. Lynn WA, Liu Y, Golenbock DT. Neither CD 14 nor serum is absolutely necessary
for activation of mononuclear phagocytes by bacterial lipopolysaccharide. 
Infect Immun 1993 Oct;61(10):4452-61.
114. Perera PY, Vogel SN, Detore GR, Haziot A, Goyert SM. CD 14-dependent and
CD 14-independent signaling pathways in murine macrophages from normal 
and CD 14 knockout mice stimulated with lipopolysaccharide or taxol. J 
Immunol 1997 May l;158(9):4422-9.
115. Vodovotz Y, BOgdon C, Paik J, Xie Q, Nathan CF. Mechanisms of suppression of
macrophage nitric oxide release by transforming growth factor beta. J Exp 
Med 1993 Aug 1;178(2):605-13.
116. Kunz D, Walker G, Eberhardt W, Pfeilschifter J. Molecular mechanisms of
dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 
beta-stimulated mesangial cells: evidence for the involvement of 
transcriptional and posttranscriptional regulation. Proc Natl Acad Sci U S A  
1996 Jan 9;93(l):255-9.
117. Walker G, Pfeilschifter J, Kunz D. Mechanisms of suppression of inducible nitric-
oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated 
RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced 
degradation of iNOS protein by calpain as a key step in post-transcriptional 
regulation. J Biol Chem 1997 Jun 27;272(26): 16679-87.
118. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by
bacterial endotoxin. Annu Rev Immunol 1995; 13:437-57:437-57.
119. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI,
Gurney AL, Godowski PJ. Toll-like receptor-2 mediates lipopolysaccharide- 
induced cellular signalling. Nature 1998 Sep 17;395(6699):284-8.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
VITA
ANNETTE RENE’ CLEMONS-MILLER
Personal Data: Date o f Birth: August 15, 1968 
Place o f Birth: Fort Collins, Colorado 
Marital Status: Married
Education: Appalachian State University, Boone, North Carolina;
Biology, B.S., December 1990 
Appalachian State University, Boone, North Carolina;
Biology, M.S., August 1993 
East Termessee State University, Johnson City, Tennessee;
Microbiology and Immunology, PhD., anticipated 1998
Publications: Miller, A.R. “Effect of high- versus moderate-intensity exercise on
immunosurveillance”. Master’s Thesis, August 1993.
Nieman, D C., Miller, A.R., Henson, D.A., Warren, B.J., 
Gusewitch, G., Johnson, R.L, Davis, J.M., Butterworth, D.E., 
Nehlsen-Cannarella, S.L., “Effects of high- vs moderate-intensity 
exercise on natural killer cell activity”. Medicine in Science Sports 
and Exercise. 1993 Oct, 25 (10): 1126-34.
Nieman, D C., Miller, A.R., Henson, D.A., Warren, B.J., 
Gusewitch, G., Johnson, R.L., Davis, J.M., Butterworth, D.E., 
Herring, J.L., Nehlsen-Cannarella, S.L., “Effect of high- vs 
moderate-intensity exercise on lymphocyte subpopulations and 
proliferative response”. International Journal of Sports Medicine. 
1994 May, 15 (4): 199-206.
Stout, R.D., Li, Y., Miller, A.R., Lambe, D.W. Jr., “Staphylococcal 
glycocalyx activates macrophage prostaglandin E2 and interleukin 1 
production and modulates tumor necrosis factor alpha and nitric 
oxide production”. Infection and Immunitv. 1994 Oct, 62 (10): 
4160-6.
Miller, A.R., Suttles, J., and Stout, R.D., “Cytokine priming 
reduces dependence on TNF-R2 for TNF-mediated induction of
67
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
68
macrophage nitric oxide generation”. Journal of Interferon and 
Cytokine Research. 1996 Dec, 16 (12): 1055-63.
Krishnaswamy, G., Lakshman, T., Miller, A.R., Srikanth, S., Hall, 
K, Huang, S.K., Suttles, J., Smith, JJC., Stout, R.D., 
“Multifunctional cytokine expression by human mast cells: 
regulation by T cell membrane contact and glucocorticoids”.
Journal of Interferon and Cvtokine Research. 1997 Mar, 17(3): 
167-76.
Miller, A.R., “TNF-dependent and TNF-independent activation of 
macrophage effector function”. Doctoral Dissertation, December 
1998.
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
IMAGE EVALUATION 
TEST TARGET (Q A -3 )
1.0
l.l
1.25
K:
1.4
m
112.2
12.0
1.8
1.6
150mm
V
cP
/
O /
/y
/4 P P U E O  A  IIVUGE . In c
. j s s  1653 East Main Street
• Rochester, NY 14609 USA 
_ _  Phone: 716/482-0300 
--------------- Fax: 716/288-5989
0 1993. Applied Image. Inc., Ail Rights R eserved
R eproduced with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
